ARUP President and Chief Scientific Officer Tracy George, MD (center), joins Kate Benedict, worldwide vice president/general manager of vascular access devices at BD, and Jared Bauer, CEO of Seek Labs, on a Workplace Innovation panel at the 2022 BioHive Summit to discuss workforce retention.
ARUP President and CSO Tracy George, MD, joined industry leaders and stakeholders at the 13th annual BioHive Summit Thursday to discuss ARUP’s employee focus, staff retention, and company culture.
New automation installed in the Automated Core Lab increases ARUP’s testing capacity, provides better turnaround times, reduces risk of human error, and improves staff satisfaction.
The near total automation installed in ARUP’s Automated Core Lab increases capacity for testing, provides better turnaround times, reduces risk of human error, and improves staff satisfaction.
Mounting evidence suggests that kratom may lead to neonatal abstinence syndrome (NAS) in infants exposed to the substance in utero.
ARUP’S new test is the first of its kind to use two distinct biomarkers to identify in utero exposure to kratom, an herbal supplement that may cause neonatal abstinence syndrome.
Pinar Bayrak-Toydemir, MD, PhD, FACMG (left), and Rong Mao, MD, FACMG (right), medical directors of Molecular Genetics and Genomics, lend their expertise to the diagnosis of rare childhood disorders through the Utah NeoSeq Project.
A $3.6 million gift from the Miller family will enable University of Utah Health and ARUP to expand and refine testing for rare genetic disorders through the Utah NeoSeq Project.
The Fall 2022 edition of Magnify: The Art and Science of Diagnostic Medicine, shares how ARUP has applied what it learned from COVID-19 to improve operations, services, and, ultimately, patient care.
ARUP Consult®, a free source of laboratory testing information for clinicians, released several new and updated resources in October.
ARUP Consult provides up-to-date guidance on test selection for the evaluation of liver function, myeloproliferative neoplasms, and hemolytic anemias.
Benjamin Bradley, MD, PhD, is set to publish his first two virology articles on monkeypox testing protocols as ARUP Laboratories’ medical director of Virology and Molecular Infectious Diseases.
Benjamin Bradley, MD, PhD, joined ARUP’s team of medical directors amid the monkeypox outbreak. Now, his new research aims to help labs improve testing.
Tracy George, MD, has been named among Utah’s Healthcare Heroes: the leaders who have made it their goal to improve health for all Utah residents.
In 2008, Megan Flipse started in ARUP's Exception Handling department in an entry-level role. Now, she oversees multiple departments as a Support Services group manager.
Group Manager Megan Flipse discusses her start as a laboratory client support technician, the completion of her medical laboratory science degree, and her career advancement at ARUP.
ARUP Consult®, a free source of laboratory testing information for clinicians, released user experience (UX) upgrades to Consult topic pages and created a new genetics homepage in September.
In September, ARUP Consult, a free informative resource in laboratory testing, released new user experience (UX) upgrades and updated several topics, including acute lymphoblastic leukemia.
Ryan Metcalf, MD, CQA(ASQ), section chief of Transfusion Medicine at ARUP and University of Utah Health, at ARUP Blood Services, a collection site for an ARUP/University of Utah Health study to determine whether convalescent plasma is an effective treatment for COVID-19.
Based on data from 21,916 participants in 33 studies, the Association for the Advancement of Blood and Biotherapies (AABB) has issued guidelines for use of convalescent plasma in COVID-19 treatment.
In her lab at the University of Utah, Allison Carey, MD, PhD, is using a molecular barcoding approach she developed to identify the genes that allow some strains of Mycobacterium avium to establish chronic infections and resist treatment with antibiotics.
The National Institute of Allergy and Infectious Diseases has awarded Medical Director Allison Carey, MD, PhD, $1.5 million over five years to fund her groundbreaking research.